While using the cerebellum as the reference region in voxel-wise analysis, we found significantly reduced mGluR5 availability only in partly hippocampus in AD patients, as shown in supplemental Fig. 1B, and there were no differences in PSS232 SUVr between AD and NC based on ROI analysis. This evidence concerns the gene GRM5 and Alzheimer disease.